NCT02481258View on ClinicalTrials.gov

A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 1, 2018

Study Completion Date

December 1, 2019

Conditions

Aortic Valve Stenosis

Interventions

DRUG

Ataciguat (HMR1766)

OTHER

Placebo Comparator: Matching Placebo

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

Mayo Clinic

OTHER

NCT02481258 - A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification | Biotech Hunter | Biotech Hunter